Vaccines work by imitating an infection and setting up a memory B-cell response in advance of an actual infection. In
Category: B-cell
Besponsa for treatment of acute lymphoblastic leukemia
Food and Drug Administration approved Besponsa for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
